Please provide your email address to receive an email when new articles are posted on . The announcement follows FDA approval of AcuFocus’ IC-8 Apthera small-aperture non-toric extended depth of focus ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

AcuFocus is an Irvine, California-based ophthalmic medical device company It has produced the IC-8 Apthera intraocular lens, which was approved by the US Food and Drug Administration last year KKR has ...

The U.S. FDA gave the greenlight to Acufocus Inc. for its IC-8 Apthera intraocular lens (IOL) for the treatment of cataracts. Like most other IOLs implanted as part of cataract surgery, the small ...

Bausch + Lomb is building out its portfolio of intraocular lenses for people with cataracts, with the acquisition of AcuFocus and its replacement implant designed to offer an extended depth of field.

AcuFocus Inc., an Irvine-based maker of devices to treat cataracts, often compares its products to a camera, saying it applies the “depth-of-focus” principle commonly used in photography. The future ...

Bausch + Lomb (NYSE:BLCO) said on Tuesday that an affiliate of it had acquired privately-held AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus. BLCO acquired AcuFocus for ...

The deal volume in 2023 is already off to a strong start in medtech. Bausch + Lomb is the latest firm to announce M&A this month. The Laval, Canada-based company said that an affiliate has acquired ...

A recent $65 million investment in Irvine-based startup medical device maker AcuFocus Inc. brought some validation for its long-term outlook as well as clues on the strategy of a much larger company ...